Advertisement

Topics

Combination of Immunotherapy and Radiation Therapy in NSCLC

07:00 EST 13 Dec 2017 | Medscape

Review the rationale and preclinical evidence for combining radiation and immunotherapy in NSCLC.
Translational Lung Cancer Research

Original Article: Combination of Immunotherapy and Radiation Therapy in NSCLC

NEXT ARTICLE

More From BioPortfolio on "Combination of Immunotherapy and Radiation Therapy in NSCLC"

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...